Home » Authors » Kim Coghill

Articles by Kim Coghill

Waxman Criticizes FDA Process; FDA Head Encourages Innovation

April 2, 2003

Palatin Raises $19M Privately For LeuTech, PT 141 Programs

April 1, 2003

Palatin Raises $19M Privately For LeuTech, PT 141 Programs

April 1, 2003

Acadia Raises $25M Privately To Advance Multiple Programs

March 31, 2003

Merck Data On Erbitux Status Appear Positive For ImClone

March 31, 2003

Merck Data On Erbitux Status Appear Positive For ImClone

March 31, 2003

Acadia Raises $25M Privately To Advance Multiple Programs

March 31, 2003

Project BioShield Raises Number Of Questions Among Lawmakers

March 28, 2003

Project BioShield Raises Number Of Questions Among Lawmakers

March 28, 2003

FDA Acceptance Puts Praecis Back On Track With Plenaxis

March 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...